NIH-funded research R37 grant

Investigating how obesity affects the response to metformin in endometrial cancer

Official title: Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer

Funded at Univ of North Carolina Chapel Hill · NIH-10790007 · Data updated 2026-11-12

This study is looking at how the diabetes medication metformin might help treat endometrial cancer in people with obesity and diabetes, and it aims to find out which patients could benefit the most from this treatment.

More Obesity research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMarch 14, 2018
Project endFebruary 28, 2026
Funding year2024
Award (this year)$337,922
NIH project number5R37CA226969-07
Project IDNIH-10790007 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are obese patients diagnosed with endometrial cancer who are also managing type 2 diabetes.

Less likely to help

Patients with endometrial cancer who are not obese or do not have diabetes may not benefit from this research.

What this research studies

This research explores the relationship between obesity, diabetes, and endometrial cancer outcomes, focusing on how metformin, a diabetes medication, may help treat this cancer. The study examines the metabolic changes induced by metformin and its potential anti-cancer effects by analyzing gene expression patterns in tumors from obese and non-obese patients. By conducting a clinical trial, the researchers aim to identify specific biomarkers that predict which patients will respond best to metformin treatment, potentially leading to more personalized therapies for endometrial cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for endometrial cancer patients, particularly those who are obese or have diabetes.

How similar studies have gone: Previous studies have shown promising results regarding the use of metformin in cancer treatment, indicating that this approach may be effective.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Bae-Jump, Victoria Lin — Univ of North Carolina Chapel Hill
  • Study coordinator: Bae-Jump, Victoria Lin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.